Malignant : how bad policy and bad evidence harm people with cancer /
"In this critical study of current cancer therapies, Dr. Prasad, an oncologist and hematologist, examines oncology practice and policy in the United States. His book is organized into four sections: (1) an overview of cancer drugs, (2) forces that distort cancer medicine and practice, (3) detai...
Clasificación: | Libro Electrónico |
---|---|
Autor principal: | |
Formato: | Electrónico eBook |
Idioma: | Inglés |
Publicado: |
Baltimore :
Johns Hopkins University Press,
2020.
|
Temas: | |
Acceso en línea: | Texto completo |
Tabla de Contenidos:
- The Basics of Cancer Drugs : Cost, Benefit, Value
- Surrogate Endpoints in Cancer : What Are They and Where Are They Used?
- Use and Misuse of Surrogates for Drug Approvals
- How High Prices Harm Patients and Society
- Hype, Spin, and the Unbridled Enthusiasm That Distorts Cancer Medicine
- Financial Conflict of Interest
- The Harms of Financial Conflicts and How to Rehabilitate Medicine
- Will Precision Oncology Save Us?
- Study Design
- Principles of Oncology Practice
- Important Trials in Oncology
- Global Oncology
- How Should Cancer Drug Development Proceed?
- What Can the US Food and Drug Administration and the Centers for Medicare and
- Medicaid Services Do Tomorrow?
- What Can People with Cancer Do?
- What Can Students, Residents, and Fellows Do?